NCT06291831View on ClinicalTrials.gov

A Study to Learn About the Use of Paxlovid in Patients With COVID-19 in the Kingdom of Bahrain.

CompletedOBSERVATIONAL

Enrollment

3,011

Participants

Timeline

Start Date

March 13, 2024

Primary Completion Date

May 14, 2024

Study Completion Date

May 14, 2024

Conditions

COVID-19

Interventions

DRUG

nirmatrelvir, ritonavir

Patients receiving Nirmatrelvir; Ritonavir (PAXLOVID)

OTHER

Controls

Patients who do not receive Nirmatrevir/ritonavir (Paxlovid)

Trial Locations (1)

Unknown

Pfizer Gulf FZ, Busaiteen

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY